Quick Summary
Gemizan 1gm Injection
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹1185
MRP: ₹5450.75
(You Save ₹4265.75)
1 VIAL(s)
78% OFF
₹1185
MRP: ₹5,450.75
Inclusive of all taxes
78% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Gemchem 1000mg Injection
NEON LABORATORI...
₹ 704.00/injection
40% cheaper
Gempharm 1gm Injection
PHARMACO INDUST...
₹ 750.00/injection
36% cheaper
Gemlieva 1gm Injection
Allieva Pharma ...
₹ 838.00/injection
29% cheaper
Apragem 1gm RTU Injection
APRAZER HEALTHC...
₹ 1001.00/injection
15% cheaper
Introduction to Gemizan 1gm Injection
Gemizan 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemizan 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemizan 1gm injection.
Uses of Gemizan 1gm Injection
Gemizan 1gm injection is used to treat
- Bladder cancer, in combination with cisplatin
- Ovarian cancer, in combination with carboplatin
- Breast cancer, in combination with paclitaxel
- Pancreatic cancer
- Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin
Therapeutic Effects of Gemizan 1gm Injection
Gemizan 1gm injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.
Interaction of Gemizan 1gm Injection with other drugs
Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interacting with Gemizan 1gm may reduce effectiveness by causing undesirable side effects.
More Information about Gemizan 1gm Injection
- Keep Gemizan 1gm injection out of sight and reach of children.
- This medicine does not require any special storage conditions.
- Do not refrigerate or freeze.
How to consume Gemizan 1gm Injection
Gemizan 1gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Safety Advice for Gemizan 1gm Injection
Breast Feeding
You must not breastfeed while being treated with Gemizan 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.
Alcohol
It is not advised to take alcohol while under this treatment because Gemizan 1gm may cause drowsiness and sleepiness. Talk to your doctor for more information.
Liver
You need to tell your doctor if you have any liver disorders before taking Gemizan 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
Lungs
Gemizan 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
Driving
Gemizan 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information.
Pregnancy
Gemizan 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Side Effects of Gemizan 1gm Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Pulmonary toxicity (shortness of breath, wheezing, cough)
- Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
- Pain or tenderness in the upper abdomen
- Allergic reactions, rashes, fever, swelling or sores in the mouth
Common
- Nausea, vomiting
- Low blood cell count
- Loss of appetite
- Hair loss
- Swelling of ankles, feet, and fingers
- Insomnia
- Constipation, diarrhea
- Headache
- Runny nose, chills
- Muscle pain, back pain
- Sweating
- hair loss
- liver problems
- blood in urine
- abnormal urine test
- Oedema (swelling of ankles, fingers, feet, face)
Word of Advice
It is not recommended to take Gemizan 1gm injection if you are allergic to Gemcitabine or any of its ingredients. During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications. This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment. Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor. It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.
FAQs about Gemizan 1gm Injection
Q1.
How does Gemizan 1gm affect cancer cells differ from healthy cells?
Gemizan 1gm affects cancer cells more than healthy cells because cancer cells have a higher rate of DNA synthesis and replication than healthy cells. Gemizan 1gm interferes with this process, which is essential for cancer cell growth and division, ultimately leading to the death of cancer cells.
Q2.
Can Gemizan 1gm be used to treat cancer in children?
No, Gemizan 1gm injection is not recommended for adolescents and children under the age of 18.
Q3.
What should I tell my doctor before starting Gemizan 1gm treatment?
Patients should inform their doctor of any pre-existing medical conditions, allergies, or medications they are taking before starting Gemizan 1gm treatment. It is also important to inform the doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Q4.
Are there any dietary or lifestyle changes that patients should make while taking Gemizan 1gm ?
Patients may need to make dietary or lifestyle changes while taking Gemizan 1gm , such as avoiding certain foods or activities that may interfere with the medication's effectiveness or cause side effects. This should be discussed with a healthcare professional.
Q5.
Does Gemizan 1gm cure cancer?
Gemizan 1gm can help slow the growth and spread of cancer cells, but it may not cure cancer on its own. It is often used in combination with other treatments, such as surgery, radiation therapy, or other chemotherapy medications, to improve the chances of a cure or long-term remission.
Q6.
How long does Gemizan 1gm treatment last?
The duration of Gemizan 1gm treatment will depend on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication. Treatment may last several weeks or months.
Fact Box of Gemizan 1gm Injection
Molecule name: Gemcitabine | Therapeutic class: Anti-Cancer |
Pharmacological class: Antimetabolites | Indications: Gemizan 1gm injection is used to treat
|
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1700.
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 870.
- Sun Pharmaceutical Industries, Electronic medicines compendium (emc), [ Revised on May 2022] [ Accessed on 20 Mar 2023], https://www.medicines.org.uk/emc/files/pil.7298.pdf
- Hospira, Inc, US Food and Drug Administration, [ Revised on June 2019 [ Accessed on 20 Mar 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020509s077lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)
Want to know more?
Read Our Editorial Policy
